Intangible capital in the pharmaceutical chemical industry;.pdfVIP

下载本文档

4
0
约3.63万字
约 22页
2016-03-09 发布于山东
举报
版权申诉

Intangible capital in the pharmaceutical chemical industry;.pdf

1、本文档共22页，可阅读全部内容。
2、有哪些信誉好的足球投注网站（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

University of New Orleans ScholarWorks@UNO Department of Economics and Finance Working Department of Economics and Finance Papers, 1991-2006 1-1-2003 Intangible capital in the pharmaceutical chemical industry; Katherine I. Gleason University of N ew Orleans Mark Klock George Washing ton University Follow this and additional works at : /econ_wp Recommended Citation Gleason, Katherine I. and Klock, Mark, Intangible capital in the pharmaceutical chemical industry; (2003). Department of Economics and Finance Working Pap ers, 1991-2006. Paper 10. /econ_wp/10 This Working Paper is brought to you for free and open access by the Department of Economics and Finance at ScholarWorks@UNO. It has been accepted for inclusion in Department of Economics and Finance Working Papers, 1991-2006 by an authorized administrator of ScholarWorks@UNO. For more information, please contact scholarworks@. February 2003 Intangible Capital in the Pharmaceutical Chemical Industry Katherine I. Gleason* ** Mark Klock contact: klock@ (202)994-8342 fax: (202)994-5014 *Assistant Professor of Finance, University of New Orleans, New Orleans, LA 70148 ** Professor of Finance, George Washington University, Washington, D.C. 20052 Abstract We investigate whether measures of intangible capital based on advertising and RD can explain variation in Tobin’s Q ratio for the pharmaceutical chemical industry using data from 1982 to 2001. The study is motivated by prior literature studying this relation in other